BCL2 and ovarian carcinoma: It was suggested that silencing the expression of EEF1D may inactivate the PI3K/Akt signaling pathway and regulate the balance of Bax/Bcl-2 to induce apoptosis, inhibit cell viability and reduce DNA damage repair in ovarian cancer cells.